ALSTON & BIRD LLP for NOVO NORDISK INC.
What was lobbied
9 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
2018 Congressional trade agenda generally.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARK RAYDER | — |
Veterans VET
Insulin pen access.
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEPHANIE CURTIS | — |
| MARK RAYDER | — |
Defense DEF
TRICARE pharmacy benefit in National Defense Authorization Act (NDAA).
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEPHANIE CURTIS | — |
| MARK RAYDER | — |
Taxation/Internal Revenue Code TAX
Implementation of Pub. L. 115-97 (H.R. 1, Tax Cuts and Jobs Act).
| Lobbyist | Covered position, as disclosed |
|---|---|
| PETER J ECKRICH | — |
| MARK RAYDER | — |
| ROBERT SIGGINS | — |
| CAROLYN E SMITH | — |
| MARILYN K YAGER | — |
Health Issues HCR
General diabetes prevention; World Hemophilia Day.
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEPHANIE CURTIS | — |
| PETER J ECKRICH | — |
| JOYCE E GRESKO | — |
| EARL POMEROY | — |
| MARK RAYDER | — |
| ROBERT SIGGINS | — |
| MARILYN K YAGER | — |
Foreign Relations FOR
Issues related to inbound investment in H.R.4311/S.2098 Foreign Investment Risk Review Modernization Act of 2017 (CFIUS Reform).
| Lobbyist | Covered position, as disclosed |
|---|---|
| PETER J ECKRICH | — |
| MARK RAYDER | — |
Medicare/Medicaid MMM
Medicare Diabetes Prevention Program; diabetes self-management education; H.R. 3124/S. 1299/Preventing Diabetes in Medicare Act; H.R. 1953/S. 830 Treat and Reduce Obesity Act; Issues related to Medicare Part D included in Section 53116 of H.R. 1892 (Pub. L. 115-123), Bipartisan Budget Act and H.R. 1625 (Pub. L. 115-141), Consolidated Appropriations Act; H.R. 849/S. 260 Protecting Seniors' Access to Medicare Act of 2017 and S. 251 Protecting Medicare from Executive Action Act of 2017 (IPAB Repeal); H.R. 3921 HEATHY KIDS Act (CHIP Reauthorization).
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEPHANIE CURTIS | — |
| PETER J ECKRICH | — |
| JOYCE E GRESKO | — |
| MARK RAYDER | — |
| ROBERT SIGGINS | — |
| MARILYN K YAGER | — |
Budget/Appropriations BUD
H.R.2953/S. 2164, Preventive Health Savings Act (CBO scoring of preventive health); National Diabetes Prevention Program and other CDC diabetes prevention activities in P.L. 115-96 (CR of FY18 Labor, Health and Human Services, and Education Appropriations).
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEPHANIE CURTIS | — |
| PETER J ECKRICH | — |
| JOYCE E GRESKO | — |
| EARL POMEROY | — |
| MARK RAYDER | — |
| ROBERT SIGGINS | — |
| MARILYN K YAGER | — |
Pharmacy PHA
Issues related to P.L. 115-52 (H.R. 2430/S. 934) FDA Reauthorization Act of 2017 (Prescription Drug User Fee Act VI); H.R. 1245/S. 469 Affordable and Safe Prescription Drug Importation Act; H.R. 1776/S. 771 Improving Access to Affordable Prescription Drugs Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEPHANIE CURTIS | — |
| MARK RAYDER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.